Home
Personen
Organisationseinheiten
Projekte
Publikationen
Schutzrechte
Core Facility
Know how
De
En
British Journal Of Haematology
Herausgeber
Wiley-Blackwell
International Standard Serial Number (ISSN )
0007-1048
Electronic International Standard Serial Number ( EISSN )
1365-2141
ISSN gedruckt
0007-1048
Weitere Details
Publikationen
Download
2024
Unveiling myeloid transformation: T-LGLL with eosinophilia masking myeloid-associated STAT5B mutation culminating in AML.
2023
Patient-derived xenograft models of ALK+ ALCL reveal preclinical promise for therapy with brigatinib.
2021
Paediatric Burkitt lymphoma patient-derived xenografts capture disease characteristics over time and are a model for therapy.
2018
Examining the function of PDGFRB in anaplastic large cell lymphoma.
2018
Investigating the functional impact of single nucleotide variants in anaplastic large cell lymphoma.
2018
The AP-1-BATF and-BATF3 module: divergent roles in tumour growth, invasion and angiogenesis in anaplastic large cell lymphoma.
2018
The anaplastic large cell lymphoma (ALCL)-associated nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) directs expression of the nuclear protein brahma related gene 1 (BRG1) driving cell survival.
2017
Expansion of
BCR/ABL1
+
cells requires PAK2 but not PAK1
2016
Anaplastic large cell lymphoma in paediatric and young adult patients
2015
Assessing the origins of anaplastic large cell lymphoma in murine models via forced lineage specificity of NPM-ALK expression in T cells.
2015
NPM-ALK mimics thymic pre-T cell receptor (TCR) expansion but requires transient TCR expression for thymic egress and peripheral anaplastic large cell lymphoma (ALCL) development.
2015
PGDFR blockade as a novel therapy for NPM-ALK(+) anaplastic large cell lymphoma.
Download
RDF/XML-Format
JSON-LD-Format
Turtle-Format
N3-Format
Publikationen
2024
Unveiling myeloid transformation: T-LGLL with eosinophilia masking myeloid-associated STAT5B mutation culminating in AML.
2023
Patient-derived xenograft models of ALK+ ALCL reveal preclinical promise for therapy with brigatinib.
2021
Paediatric Burkitt lymphoma patient-derived xenografts capture disease characteristics over time and are a model for therapy.
2018
Examining the function of PDGFRB in anaplastic large cell lymphoma.
2018
Investigating the functional impact of single nucleotide variants in anaplastic large cell lymphoma.
2018
The AP-1-BATF and-BATF3 module: divergent roles in tumour growth, invasion and angiogenesis in anaplastic large cell lymphoma.
2018
The anaplastic large cell lymphoma (ALCL)-associated nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) directs expression of the nuclear protein brahma related gene 1 (BRG1) driving cell survival.
2017
Expansion of
BCR/ABL1
+
cells requires PAK2 but not PAK1
2016
Anaplastic large cell lymphoma in paediatric and young adult patients
2015
Assessing the origins of anaplastic large cell lymphoma in murine models via forced lineage specificity of NPM-ALK expression in T cells.
2015
NPM-ALK mimics thymic pre-T cell receptor (TCR) expansion but requires transient TCR expression for thymic egress and peripheral anaplastic large cell lymphoma (ALCL) development.
2015
PGDFR blockade as a novel therapy for NPM-ALK(+) anaplastic large cell lymphoma.
Download
Download
RDF/XML-Format
JSON-LD-Format
Turtle-Format
N3-Format